Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/23/1998 | EP0885901A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
12/23/1998 | EP0885887A2 Sulfonamide inhibitors of HIV-Aspartyl protease |
12/23/1998 | EP0885881A2 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
12/23/1998 | EP0885880A2 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
12/23/1998 | EP0885302A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
12/23/1998 | EP0885299A1 Wsx receptor and ligands |
12/23/1998 | EP0885297A1 Novel era |
12/23/1998 | EP0885237A1 Oligonucleotide analogues |
12/23/1998 | EP0885236A1 Oligonucleotide analogs |
12/23/1998 | EP0885234A1 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs |
12/23/1998 | EP0885229A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
12/23/1998 | EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
12/23/1998 | EP0885010A1 Intercellular adhesion molecule powder formulation |
12/23/1998 | EP0885003A1 Use of hexahydrolupulones as antibacterial and anticancer agents |
12/23/1998 | EP0884997A1 Compositions containing an antifungal and a sulfur compound |
12/23/1998 | EP0884950A1 A method of killing or inhibiting microbial cells |
12/23/1998 | CN1202907A Cyclopeptide derivatives |
12/23/1998 | CN1202905A Parainfluenza virus glycoproteins and vaccines |
12/23/1998 | CN1202904A Cyclopeptolides |
12/23/1998 | CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists |
12/23/1998 | CN1202829A Method for preserving microoganisms |
12/23/1998 | CN1202523A Live attenuated bacteria of species actinobacillus pleuropneumoniae |
12/23/1998 | CN1202359A Medicine for preventing sexual disease |
12/23/1998 | CA2295440A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
12/23/1998 | CA2294569A1 Secreted proteins and polynucleotides encoding them |
12/23/1998 | CA2294398A1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same |
12/23/1998 | CA2294281A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
12/23/1998 | CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds |
12/23/1998 | CA2294051A1 Adjuvant compositions for vaccines |
12/23/1998 | CA2293732A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
12/23/1998 | CA2293614A1 Adjuvant compositions for vaccines |
12/23/1998 | CA2293418A1 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
12/23/1998 | CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
12/22/1998 | US5852195 Pyranone compounds useful to treat retroviral infections |
12/22/1998 | US5852188 Oligonucleotides having chiral phosphorus linkages |
12/22/1998 | US5852186 Reactive neutralizing human anti-GP120 recombinant antibody, DNA coding the same and use thereof |
12/22/1998 | US5852180 Chemical synthesis of 6-O-alkyl erythromycin A |
12/22/1998 | US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
12/22/1998 | US5852043 HIV protease inhibitors |
12/22/1998 | US5851996 Materials and methods for treatment of plaquing diseases |
12/22/1998 | US5851978 Soap composition |
12/22/1998 | US5851828 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
12/22/1998 | US5851827 DNA encoding clostridium perfringens alpha-toxin peptides |
12/22/1998 | US5851814 Human elastate IV |
12/22/1998 | US5851809 Tryptophanyl tRNA Synthetase polynucleotides of Streptococcus |
12/22/1998 | US5851533 Vaccine based on membrane bound proteins and process for making them |
12/22/1998 | CA2071955C Reduced-protein subunit vaccine for swine dysentery |
12/22/1998 | CA2008775C Nail lacquer |
12/22/1998 | CA2001201C Antimicrobial quinolonyl lactams esters |
12/22/1998 | CA1340285C Novel quinolonecarboxylic acid derivatives having at 7-position a piperidin-1-yl substituent |
12/22/1998 | CA1340281C Process for preparing and purifying alpha-interferon |
12/20/1998 | CA2235444A1 Novel compounds |
12/20/1998 | CA2235442A1 Response regulator |
12/20/1998 | CA2235441A1 Novel compounds |
12/20/1998 | CA2235437A1 Novel compounds |
12/20/1998 | CA2235435A1 Novel compounds |
12/20/1998 | CA2235433A1 Novel compounds |
12/20/1998 | CA2235422A1 Novel compounds |
12/18/1998 | CA2239605A1 Novel g-protein coupled receptor (h7tba62) |
12/17/1998 | WO1998057176A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents |
12/17/1998 | WO1998057175A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma |
12/17/1998 | WO1998056931A1 Attenuated recombinant mycobacteria useful as immunogens or as vaccine components |
12/17/1998 | WO1998056929A1 Dna sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
12/17/1998 | WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
12/17/1998 | WO1998056901A2 Live attenuated vaccines |
12/17/1998 | WO1998056820A1 Hm74a receptor |
12/17/1998 | WO1998056818A1 Human l105 proteins and polynucleotides encoding same |
12/17/1998 | WO1998056816A1 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE |
12/17/1998 | WO1998056802A1 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
12/17/1998 | WO1998056801A1 C-4''-substituted macrolide derivatives |
12/17/1998 | WO1998056800A1 9-oxime erythromycin derivatives |
12/17/1998 | WO1998056761A2 Benzimidazole derivatives |
12/17/1998 | WO1998056414A1 Oil in water vaccine compositions |
12/17/1998 | WO1998056413A1 Multivalent in ovo avian vaccine |
12/17/1998 | WO1998056411A1 Novel antimicrobial polypeptide and methods of use |
12/17/1998 | WO1998056398A2 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
12/17/1998 | WO1998056392A1 INHIBITORS OF β-LACTAMASES AND USES THEREFOR |
12/17/1998 | WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds |
12/17/1998 | WO1998056358A1 Rapamycin formulations for oral administration |
12/17/1998 | WO1998056325A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes |
12/17/1998 | WO1998040401A3 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
12/17/1998 | WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
12/17/1998 | CA2301196A1 Multivalent in ovo avian vaccine |
12/17/1998 | CA2295982A1 Human l105 proteins and polynucleotides encoding same |
12/17/1998 | CA2295176A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes |
12/17/1998 | CA2294057A1 Novel pyrazole and pyrazoline substituted compounds |
12/17/1998 | CA2293826A1 Attenuated recombinant mycobacteria useful as immunogens or as vaccine components |
12/17/1998 | CA2293444A1 Oil in water vaccine compositions |
12/17/1998 | CA2293350A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma |
12/17/1998 | CA2293335A1 9-oxime erythromycin derivatives |
12/17/1998 | CA2293293A1 Vaccine compositions comprising the helicobacter pylori flge polypeptide |
12/17/1998 | CA2292900A1 Live attenuated vaccines |
12/17/1998 | CA2291653A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents |
12/17/1998 | CA2291645A1 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
12/17/1998 | CA2291055A1 Inhibitors of .beta.-lactamases and uses therefor |
12/17/1998 | CA2263993A1 Method of attenuating viruses |
12/16/1998 | EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML) |
12/16/1998 | EP0884387A2 Human 7-transmembrane receptor HLWAR77 |
12/16/1998 | EP0884385A1 Intracellular modulators of apoptopic cell death pathways |
12/16/1998 | EP0884382A2 Processes for preparation of marek's disease virus using continuous mammalian cell lines |